Previously infected vaccinees broadly neutralize SARS-CoV-2 variants of concern

By | May 3, 2021
Researchers in the United States have conducted a study demonstrating the effectiveness of first-generation vaccines at protecting against variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals who have previously been infected with the virus.